TargetMol

Dobutamine lactobionate

Product Code:
 
TAR-T31560
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31560-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31560-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31560-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Dobutamine lactobionate is a cardiotonic.
CAS:
104564-71-8
Formula:
C30H45NO15
Molecular Weight:
659.682
Purity:
0.98
SMILES:
CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1.OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(O)=O

References

1. Roman-Pognuz E, Elmer J, Rittenberger JC, Guyette FX, Berlot G, De Rosa S, Peratoner A, de Arroyabe BML, Lucangelo U, Callaway CW. Markers of cardiogenic shock predict persistent acute kidney injury after out of hospital cardiac arrest. Heart Lung. 2018 Nov 20. pii: S0147-9563(18)30194-8. doi: 10.1016/j.hrtlng.2018.10.025. [Epub ahead of print] PubMed PMID: 30470603. 2. van den Akker JPC, Bakker J, Groeneveld ABJ, den Uil CA. Risk indicators for acute kidney injury in cardiogenic shock. J Crit Care. 2018 Nov 10;50:11-16. doi: 10.1016/j.jcrc.2018.11.004. [Epub ahead of print] PubMed PMID: 30465893. 3. Stacey RB, Vera T, Morgan TM, Jordan JH, Whitlock MC, Hall ME, Vasu S, Hamilton C, Kitzman DW, Hundley WG. Asymptomatic myocardial ischemia forecasts adverse events in cardiovascular magnetic resonance dobutamine stress testing of high-risk middle-aged and elderly individuals. J Cardiovasc Magn Reson. 2018 Nov 22;20(1):75. doi: 10.1186/s12968-018-0492-5. PubMed PMID: 30463565. 4. Cortigiani L, Ramirez P, Coltelli M, Bovenzi F, Picano E. Drop-off in positivity rate of stress echocardiography based on regional wall motion abnormalities over the last three decades. Int J Cardiovasc Imaging. 2018 Nov 20. doi: 10.1007/s10554-018-1501-3. [Epub ahead of print] PubMed PMID: 30460582.